Amir Halkin1, Arie Steinvil2, Guy Witberg3, Alon Barsheshet3, Michael Barkagan2, Abid Assali3, Amit Segev4, Paul Fefer4, Victor Guetta4, Israel M Barbash4, Ran Kornowski3, Ariel Finkelstein2. 1. Department of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: amirh@tlvmc.gov.il. 2. Department of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 3. Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 4. Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract
BACKGROUND: Accurate risk stratification is pivotal for appropriate selection of patients with severe symptomatic aortic stenosis for either surgical or transcatheter aortic valve replacement (TAVR). We sought to determine whether recent risk prediction models developed specifically in TAVR patients enhance prognostication in comparison with previous surgical scores used in clinical practice (EuroScore I, EuroScore II, STS). METHODS: The Israeli TAVR Registry Risk Model Accuracy Assessment (IRRMA) study utilized a multicenter prospective TAVR database (n=1327) to perform a quantitative comparison between previous risk scores developed in either surgical or TAVR populations, with the present registry serving as an independent external validation set. RESULTS: In the IRRMA population, 4 variables (NYHA functional class IV, chronic obstructive pulmonary disease, systolic pulmonary artery pressure ≥60mmHg, vascular access other than by the femoral route) identified by cross-validation and leave-one-out analyses provided the most discriminative model (C-statistic=0.63) for predicting 30-day mortality. Previous scores developed in surgical (EuroScores I and II, STS), TAVR (FRANCE-2, OBSERVANT), or mixed (German AV score) populations were applied to the IRRMA cohort. Resultant C-statistics ranged between 0.52-0.71 (for the German AV and FRANCE-2 scores, respectively) and did not differ significantly (p=0.07 for the comparison between the lowest and highest C-statistics). The observed C-statistic for 5 of these 6 scores was lower than originally reported when applied to the IRRMA population. CONCLUSION: Available TAVR risk scores showed limited accuracy when applied to an independent validation set and did not enhance prognostication in comparison to previous surgical scores.
BACKGROUND: Accurate risk stratification is pivotal for appropriate selection of patients with severe symptomatic aortic stenosis for either surgical or transcatheter aortic valve replacement (TAVR). We sought to determine whether recent risk prediction models developed specifically in TAVR patients enhance prognostication in comparison with previous surgical scores used in clinical practice (EuroScore I, EuroScore II, STS). METHODS: The Israeli TAVR Registry Risk Model Accuracy Assessment (IRRMA) study utilized a multicenter prospective TAVR database (n=1327) to perform a quantitative comparison between previous risk scores developed in either surgical or TAVR populations, with the present registry serving as an independent external validation set. RESULTS: In the IRRMA population, 4 variables (NYHA functional class IV, chronic obstructive pulmonary disease, systolic pulmonary artery pressure ≥60mmHg, vascular access other than by the femoral route) identified by cross-validation and leave-one-out analyses provided the most discriminative model (C-statistic=0.63) for predicting 30-day mortality. Previous scores developed in surgical (EuroScores I and II, STS), TAVR (FRANCE-2, OBSERVANT), or mixed (German AV score) populations were applied to the IRRMA cohort. Resultant C-statistics ranged between 0.52-0.71 (for the German AV and FRANCE-2 scores, respectively) and did not differ significantly (p=0.07 for the comparison between the lowest and highest C-statistics). The observed C-statistic for 5 of these 6 scores was lower than originally reported when applied to the IRRMA population. CONCLUSION: Available TAVR risk scores showed limited accuracy when applied to an independent validation set and did not enhance prognostication in comparison to previous surgical scores.
Authors: Timothy S Lancaster; Matthew R Schill; Jason W Greenberg; Chawannuch Ruaengsri; Richard B Schuessler; Jennifer S Lawton; Hersh S Maniar; Michael K Pasque; Marc R Moon; Ralph J Damiano; Spencer J Melby Journal: Ann Thorac Surg Date: 2017-12-19 Impact factor: 4.330
Authors: Didrik Kjønås; Gry Dahle; Henrik Schirmer; Siri Malm; Jo Eidet; Lars Aaberge; Terje Steigen; Svend Aakhus; Rolf Busund; Assami Rösner Journal: Health Sci Rep Date: 2021-05-06
Authors: Didrik Kjønås; Gry Dahle; Henrik Schirmer; Siri Malm; Jo Eidet; Lars Aaberge; Terje Steigen; Svend Aakhus; Rolf Busund; Assami Rösner Journal: Open Heart Date: 2019-04-23
Authors: Hatem Al-Farra; Bas A J M de Mol; Anita C J Ravelli; W J P P Ter Burg; Saskia Houterman; José P S Henriques; Ameen Abu-Hanna; M M Vis; J Vos; L Timmers; W A L Tonino; C E Schotborgh; V Roolvink; F Porta; M G Stoel; S Kats; G Amoroso; H W van der Werf; P R Stella; P de Jaegere Journal: Int J Cardiol Heart Vasc Date: 2021-01-23
Authors: Glen P Martin; Matthew Sperrin; Peter F Ludman; Mark A de Belder; Chris P Gale; William D Toff; Neil E Moat; Uday Trivedi; Iain Buchan; Mamas A Mamas Journal: Am Heart J Date: 2016-11-03 Impact factor: 4.749
Authors: Glen P Martin; Matthew Sperrin; Peter F Ludman; Mark A deBelder; Mark Gunning; John Townend; Simon R Redwood; Umesh T Kadam; Iain Buchan; Mamas A Mamas Journal: BMJ Open Date: 2018-06-30 Impact factor: 2.692
Authors: Glen P Martin; Matthew Sperrin; Peter F Ludman; Mark A de Belder; Simon R Redwood; Jonathan N Townend; Mark Gunning; Neil E Moat; Adrian P Banning; Iain Buchan; Mamas A Mamas Journal: Heart Date: 2017-12-07 Impact factor: 5.994
Authors: M S van Mourik; J F Velu; V R Lanting; J Limpens; B J Bouma; J J Piek; J Baan; J P S Henriques; M M Vis Journal: Neth Heart J Date: 2020-05 Impact factor: 2.380